Universal Clinical Codes & Terminology Search

Programming device evaluation of implanted neurostimulator pulse generator system for central sleep apnea; single session

Oncology chemotherapeutic drug cytotoxicity assay of cancer stem cells (CSCs) from cultured CSCs and primary tumor cells categorical drug response reported based on cytotoxicity percentage observed minimum of 14 drugs or drug combinations

Programming device evaluation of implanted neurostimulator pulse generator system for central sleep apnea; during sleep study

Oncology (lung) plasma analysis of 388 proteins using aptamer-based proteomics technology predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy

Implantation of non-biologic or synthetic implant (eg polypropylene) for fascial reinforcement of the abdominal wall (List separately in addition to code for primary procedure)

Psychiatry (anxiety disorders) mRNA gene expression profiling by RNA sequencing of 15 biomarkers whole blood algorithm reported as predictive risk score

Transperineal placement of biodegradable material peri-prostatic (via needle) single or multiple includes image guidance

Drug metabolism (adverse drug reactions and drug response) buccal specimen gene-drug interactions variant analysis of 33 genes including deletion/duplication analysis of CYP2D6 including reported phenotypes and impacted gene-drug interactions

Myocardial contrast perfusion echocardiography at rest or with stress for assessment of myocardial ischemia or viability (List separately in addition to code for primary procedure)

Cardiology (coronary heart disease [CHD]) DNA analysis of 5 single-nucleotide polymorphisms (SNPs) (rs11716050 [LOC105376934] rs6560711 [WDR37] rs3735222 [SCIN/LOC107986769] rs6820447 [intergenic] and rs9638144 [ESYT2]) and 3 DNA methylation markers (cg00300879 [transcription start site {TSS200} of CNKSR1] cg09552548 [intergenic] and cg14789911 [body of SPATC1L]) qPCR and digital PCR whole blood algorithm reported as a 4-tiered risk score for a 3-year risk of symptomatic CHD

Ablation percutaneous cryoablation includes imaging guidance; upper extremity distal/peripheral nerve

Cardiology (coronary heart disease [CHD]) DNA analysis of 10 single-nucleotide polymorphisms (SNPs) (rs710987 [LINC010019] rs1333048 [CDKN2B-AS1] rs12129789 [KCND3] rs942317 [KTN1-AS1] rs1441433 [PPP3CA] rs2869675 [PREX1] rs4639796 [ZBTB41] rs4376434 [LINC00972] rs12714414 [TMEM18] and rs7585056 [TMEM18]) and 6 DNA methylation markers (cg03725309 [SARS1] cg12586707 [CXCL1 cg04988978 [MPO] cg17901584 [DHCR24-DT] cg21161138 [AHRR] and cg12655112 [EHD4]) qPCR and digital PCR whole blood algorithm r

Ablation percutaneous cryoablation includes imaging guidance; lower extremity distal/peripheral nerve

Infectious disease (bacterial fungal or viral infection) semiquantitative biomechanical assessment (via deformability cytometry) whole blood with algorithmic analysis and result reported as an index

Ablation percutaneous cryoablation includes imaging guidance; nerve plexus or other truncal nerve (eg brachial plexus pudendal nerve)

Infectious disease (respiratory infection) Myxovirus resistance protein A (MxA) and C-reactive protein (CRP) fingerstick whole blood specimen each biomarker reported as present or absent

Real-time spectral analysis of prostate tissue by fluorescence spectroscopy including imaging guidance (List separately in addition to code for primary procedure)

Neurofilament light chain (NfL) ultra-sensitive immunoassay serum or cerebrospinal fluid

Initial placement of a drug-eluting ocular insert under one or more eyelids including fitting training and insertion unilateral or bilateral

Oncology (solid organ neoplasia) targeted genomic sequence analysis panel of 361 genes interrogation for gene fusions translocations or other rearrangements using DNA from formalin-fixed paraffin-embedded (FFPE) tumor tissue report of clinically significant variant(s)